(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SYNCVIEW

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SYNCVIEW

ST13

US500000087870228

Class

42

Filing

87870228

Registration

5801570

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

10/16/2025

Trademark type

Word

Nice classes

42

Filing date

04/10/2018

Registration date

07/09/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/15/2025

Last transaction

10/16/2025

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/25/2019

First use in commerce

03/25/2019

Drawing code

4

Owner type

03

Owner location

Plymouth, MI

Examiner

STEDMAN, CORI

Current location

Historical data usage

Holders and representatives

Holders

PHENOMICS HEALTH INC.
PRECERA BIOSCIENCE, INC.
Sano Informed Prescribing, Inc.

Representatives

Roger H. Bora Thompson Hine LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Scientific and technological services featuring testinganalysis and evaluation of blood samples for the purpose of drug development by othersdata-driven analytics and reporting to developers of drugs; scientific and technological services featuring testinganalysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare servicesspecifically for improving the monitoring and diagnostics of quantitative patient drug exposuremonitoring and diagnostics of patient drug compliancedata-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activitiesdrug dosage recommendationsinitial drug prescribingdrug switchingall for research purposes and not for medical purposes

Publications

History of USPTO decisions and trademark events.

29 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

10/15/2025

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

10/15/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/15/2025

E815

TEAS SECTION 8 & 15 RECEIVED

06/11/2025

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/09/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/02/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/02/2019

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

09/25/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

07/09/2019

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

06/04/2019

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

06/01/2019

SUPC

STATEMENT OF USE PROCESSING COMPLETE

04/30/2019

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

04/10/2019

IUAF

USE AMENDMENT FILED

03/26/2019

EISU

TEAS STATEMENT OF USE RECEIVED

03/26/2019

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/02/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/07/2018

PUBO

PUBLISHED FOR OPPOSITION

08/07/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/18/2018

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

07/04/2018

ALIE

ASSIGNED TO LIE

06/29/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/18/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

06/14/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

06/14/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

06/14/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/14/2018

DOCK

ASSIGNED TO EXAMINER

06/14/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/18/2018

NWAP

NEW APPLICATION ENTERED

04/13/2018

Continuous trademark protection

Get notified about every new filing that threatens SYNCVIEW or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.